CME Group Inc (NASDAQ:CME) has been given a consensus rating of “Buy” by the sixteen ratings firms that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $157.00.
CME has been the subject of several research reports. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research report on Tuesday, January 2nd. Goldman Sachs Group upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price for the company in a research report on Wednesday, February 7th. Citigroup restated a “buy” rating and set a $172.00 target price (up from $155.00) on shares of CME Group in a research report on Monday, January 29th. Finally, Berenberg Bank initiated coverage on shares of CME Group in a research report on Thursday, January 25th. They set a “hold” rating and a $170.00 target price for the company.
In related news, Chairman Terrence A. Duffy sold 20,000 shares of the company’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total transaction of $3,033,200.00. Following the completion of the transaction, the chairman now owns 99,239 shares in the company, valued at $15,050,586.74. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction on Wednesday, February 14th. The stock was sold at an average price of $159.91, for a total transaction of $31,982.00. Following the transaction, the director now owns 3,809 shares of the company’s stock, valued at approximately $609,097.19. The disclosure for this sale can be found here. Over the last quarter, insiders sold 64,728 shares of company stock valued at $9,755,257. Company insiders own 0.57% of the company’s stock.
Shares of CME Group (NASDAQ:CME) traded down $2.73 during trading on Wednesday, reaching $162.38. 1,448,900 shares of the company’s stock traded hands, compared to its average volume of 1,703,312. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.05. The stock has a market capitalization of $55,260.00, a PE ratio of 37.07, a PEG ratio of 2.10 and a beta of 0.64. CME Group has a twelve month low of $114.82 and a twelve month high of $165.35.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. During the same period in the previous year, the company earned $1.14 earnings per share. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. research analysts forecast that CME Group will post 6.32 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be given a $0.70 dividend. This is a positive change from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s dividend payout ratio is presently 60.27%.
COPYRIGHT VIOLATION WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.com-unik.info/2018/02/19/cme-group-inc-cme-given-consensus-rating-of-buy-by-brokerages.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.